Novartis to spin-off its generics and biosimilars unit Sandoz
With the planned spin-off, Sandoz will become a large-scale, independent company focused on biosimilars, antibiotics and generic medicines,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Aug 22
With the planned spin-off, Sandoz will become a large-scale, independent company focused on biosimilars, antibiotics and generic medicines,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 Aug 22
Imbruvica is a once-daily oral medication, jointly developed by Janssen and AbbVie’s subsidiary Pharmacyclics, that works by blocking…
25 Aug 22
The global weight loss supplements market share is expected to grow from $30.12 billion in 2021 to $34.19 billion in 2022 at…
25 Aug 22
The new flavors join original Freshie Lime flavor and come in four-packs and a new eight-can variety pack,…
25 Aug 22
Energy efficient appliances? Rebate. Eco-friendly car? Rebate. Now, choosing sustainable bacon earns its own rewards. Claiming the Bacon…
NutraceuticalsProtein and Peptide Synthesis and Manufacturing
25 Aug 22
The new facility in Plainville, Massachusetts is intended to manufacture materials central to the production of gene-based therapeutics
24 Aug 22
In the updated analysis, the Pfizer-BioNTech Covid-19 vaccine showed 73.2% efficacy in children aged six months to four…
24 Aug 22
MK-2060 is a monoclonal antibody under development which is intended to block Factor XI's capacity to activate downstream…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 Aug 22
In addition to the joint development projects, Zerion has granted Hovione an exclusive license to exploit the Dispersome®…
23 Aug 22
The EC authorisation for Sunlenca is said to provide a new, every six-month treatment option for people with…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates